Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03227068 · ClinicalTrials.gov registry record · NA
Parent Educational Discharge Support Strategies
A NA study of Educational Activities, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 289
- Enrollment target
- 16
- Study locations
NCT03227068: Completed NA study of Educational Activities, sponsored by Duke University.
NCT03227068 is a NA study of Educational Activities that has completed, run by Duke University. The registered enrollment target is 289 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 16 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03227068, a NA study of Educational Activities, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 289 participants
- Enrollment target
- 16
- Study locations
Study Summary
After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. Parents want concise, focused information on how to care for their child after the hospital discharge. Two parent education discharge support strategies (PEDSS) were created to use at hospital discharge. PEDSS consists of a symptom management intervention and a support for the caregiver intervention. A cluster randomized control trial will assess the effectiveness and feasibility of the two different interventions.
Primary Outcome
Wong-Baker Faces Scale
Conditions Studied
Interventions
- OTHER PEDSS - symptom management
- OTHER PEDSS - support for the caregiver
Study Locations (16)
Illinois
- Ann and Robert H. Lurie Children's Hospital of Chicago - Chicago
- Northwestern Central DuPage Hospital - Winfield
North Carolina
- Levine Children's Hospital - Charlotte
- Duke University Medical Center - Durham
Florida
- Nicklaus Children's Hospital - Miami
Maine
- Maine Children's Cancer Program at Maine Medical Center - Scarborough
Missouri
- St. Louis Children's Hospital - St Louis
New Jersey
- St. Peter's University Hospital - New Brunswick
New York
- Cohen Children's Medical Center Northwell Health - New Hyde Park
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2017-12-29 |
| Est. Completion | 2020-06-29 |
| Phase | NA |
What the finished NCT03227068 record still lists
NCT03227068 is an interventional study that assigns participants to a tested intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Educational Activities appearing as the primary indexed condition, and to 2 interventions - of which PEDSS - symptom management is the first listed.
NCT03227068 lists 16 locations in 14 states (Illinois, North Carolina, Florida).
Frequently Asked Questions
What is clinical trial NCT03227068 about?
NCT03227068 is a clinical study titled "Parent Educational Discharge Support Strategies". After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. P...
What is the current status of trial NCT03227068?
This trial is currently completed. It is a NA study. The enrollment target is 289 participants. The study started on 2017-12-29. Estimated completion is 2020-06-29.
What conditions does trial NCT03227068 study?
This clinical trial studies the following conditions: Educational Activities.
What interventions are being tested in trial NCT03227068?
The interventions under investigation include: PEDSS - symptom management (OTHER), PEDSS - support for the caregiver (OTHER).
Who is sponsoring clinical trial NCT03227068?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03227068 being conducted?
This trial has 16 study locations across Florida, Illinois, Maine, Missouri, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Educational Activities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03227068's enrollment target sits among peer trials
289 376th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI